We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+1.06%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$355M
AUM Growth
-$58.3M
Cap. Flow
-$49.6M
Cap. Flow %
-13.96%
Top 10 Hldgs %
19.68%
Holding
1,105
New
222
Increased
181
Reduced
330
Closed
90

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$24.9M
2
RACE icon
Ferrari
RACE
+$19.1M
3
CNH
CNH Industrial
CNH
+$12.3M
4
IVE icon
iShares S&P 500 Value ETF
IVE
+$8.23M
5
UBS icon
UBS Group
UBS
+$5.09M

Sector Composition

Rank Sector Weight
1 Miscellaneous 18.09%
2 Technology 16.07%
3 Consumer Discretionary 9.4%
4 Healthcare 9.16%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ERTH icon
401
Invesco MSCI Sustainable Future ETF
ERTH
$127M
$151K 0.04%
2,459
ARMK icon
402
Aramark
ARMK
$15.5B
$150K 0.04%
5,540
-3,339
-38% -$87.1K
ACTDU
403
DELISTED
ArcLight Clean Transition Corp. II Unit
ACTDU
$150K 0.04%
15,000
-25,000
-63% -$253K
NEWR
404
DELISTED
New Relic, Inc.
NEWR
$149K 0.04%
2,229
-254
-10% -$20.8K
PBR icon
405
Petrobras
PBR
$136B
$147K 0.04%
9,966
+9,886
+12,358% +$132K
PNR icon
406
Pentair
PNR
$9.16B
$147K 0.04%
2,717
-402
-13% -$24.3K
BMRN icon
407
BioMarin Pharmaceuticals
BMRN
$12.6B
$146K 0.04%
1,889
-220
-10% -$18.4K
SPTI icon
408
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.5B
$146K 0.04%
4,804
FSLR icon
409
First Solar
FSLR
$20.7B
$145K 0.04%
1,736
-46
-3% -$3.52K
IEI icon
410
iShares 3-7 Year Treasury Bond ETF
IEI
$17.3B
$144K 0.04%
1,178
-1,389
-54% -$174K
BLK icon
411
Blackrock
BLK
$163B
$144K 0.04%
188
-176
-48% -$138K
GSG icon
412
iShares S&P GSCI Commodity-Indexed Trust
GSG
$1.06B
$143K 0.04%
+6,316
New +$130K
AWK icon
413
American Water Works
AWK
$27.5B
$142K 0.04%
856
-1,678
-66% -$266K
DOO
414
Bombardier Recreational Products
DOO
$4.25B
$141K 0.04%
1,727
-349
-17% -$26.5K
LULU icon
415
lululemon athletica
LULU
$10.9B
$140K 0.04%
384
+55
+17% +$17.9K
ULTA icon
416
Ulta Beauty
ULTA
$22.9B
$140K 0.04%
+352
New +$133K
CASH icon
417
Pathward Financial
CASH
$1.65B
$140K 0.04%
2,546
+2,385
+1,481% +$135K
CVNA icon
418
Carvana
CVNA
$48.4B
$139K 0.04%
5,840
+620
+12% +$18.1K
ECL icon
419
Ecolab
ECL
$77.5B
$139K 0.04%
789
-115
-13% -$21.6K
ZION icon
420
Zions Bancorporation
ZION
$9.79B
$139K 0.04%
+2,120
New +$145K
MU icon
421
Micron Technology
MU
$1.05T
$138K 0.04%
1,778
-348
-16% -$29.7K
CMA
422
DELISTED
Comerica
CMA
$137K 0.04%
1,514
-13
-0.9% -$1.23K
TBBK icon
423
The Bancorp
TBBK
$2.08B
$136K 0.04%
4,816
-4
-0.1% -$115
SIVB
424
DELISTED
SVB Financial Group
SIVB
$136K 0.04%
243
+51
+27% +$31K
AWAY icon
425
Amplify Travel Tech ETF
AWAY
$26.7M
$135K 0.04%
5,703
-2,028
-26% -$47.6K

Similar funds

Exane Derivatives's Q1 2022 Portfolio in Review

As of Q1 2022, Exane Derivatives held 1,105 positions worth $355M, down 14% from $413M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Exane Derivatives withdrew a net $49.6M in Q1 2022, closing 90 positions and reducing 330 holdings. Its most notable exit was iShares S&P 500 Value ETF, an estimated $8.23M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Exane Derivatives opened a new position in Visa worth $4.62M.

  • Exane Derivatives's largest Q1 2022 buy was Visa: 20,811 shares worth $4.62M.
  • Exane Derivatives added most to iShares MSCI China ETF in Q1 2022, an estimated $5.54M increase.
  • Exane Derivatives's biggest Q1 2022 reduction was Stellantis, cutting an estimated $24.9M.
  • Exane Derivatives fully exited iShares S&P 500 Value ETF in Q1 2022, selling an estimated $8.23M.
  • Exane Derivatives's ten largest holdings make up 20% of its $355M portfolio in Q1 2022.
  • Exane Derivatives opened 222 new positions and closed 90 in Q1 2022.
  • Exane Derivatives's portfolio value fell 14% quarter-over-quarter to $355M.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.